Yuksek Ihtisas Hospital
Ankara, Cankaya, 06100, Turkey (Türkiye)
NCT Number: NCT02044315
The aim of the present study is to investigate whether increasing detection zones can effectively reduce inappropriate ICD therapies in primary prevention patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2 / Phase 3
Ankara, Cankaya, 06100, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
Occurence of first total inappropriate therapy at 12-month follow-up
Time frame: 12 months
Occurence of first total appropriate therapy at 12-month follow-up
Time frame: 12 months
Occurence of all-cause mortality at 12-month follow-up
Time frame: 12 months
Occurence of hospitalization for heart failure at 12-month follow-up
Yuksek Ihtisas Hospital
Other
Acronym: RISSY-ICD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.